On the contrary, olmesartan, an AT1 receptor blocker (ARB), was also shown to have high antioxidant activity, with effects similar to those reported previously [18–20] in model rats with ANG-II-induced hypertension. Here, AGTR1 is linked to hypertensive disorder.